RXO Forecast, price target & analysts
RXO Target price 2025 - Analyst rating & recommendation
RXO Classifications & Recommendation:
RXO Price Target
| Target Price | $15.30 |
| Price | $14.43 |
| Potential |
6.03%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target RXO 2026 .
The average RXO target price is $15.30.
This is
6.03%
register free of charge
$21.00
45.53%
register free of charge
$10.10
30.01%
register free of charge
|
|
| A rating was issued by 26 analysts: 8 Analysts recommend RXO to buy, 16 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the RXO stock has an average upside potential 2026 of
6.03%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 4.55 | 5.92 |
| 15.86% | 30.18% | |
| EBITDA Margin | 2.59% | 2.48% |
| 24.56% | 4.37% | |
| Net Margin | -6.37% | 0.32% |
| 6,357.31% | 105.02% |
23 Analysts have issued a sales forecast RXO 2025 . The average RXO sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an RXO EBITDA forecast 2025. The average RXO EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
23 RXO Analysts have issued a net profit forecast 2025. The average RXO net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.17 | 0.12 |
| 7,333.33% | 105.53% | |
| P/E | 123.11 | |
| EV/Sales | 0.46 |
23 Analysts have issued a RXO forecast for earnings per share. The average RXO EPS is
This results in the following potential growth metrics and future valuations:
Current RXO Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wolfe Research |
Locked
➜
Locked
|
Locked | Nov 14 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| Susquehanna |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Oct 10 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wolfe Research:
Locked
➜
Locked
|
Nov 14 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
Susquehanna:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Oct 10 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
